Dataset Information

A multi-sensory dataset for the activities of daily living.

ABSTRACT: The article describes a multi-sensory dataset related to the Activities of Daily Living (ADL). These are the activities that contribute to an assessment of the overall status of elderly or people with special needs, possibly suffering from mild cognitive impairments. Typical basic ADLs include walking, such postural transitions as getting up or sitting down, as well as behaviours related to feeding, such as drinking or eating with knife and fork, or personal hygiene, e.g., teeth brushing. The collection process adopted for building this dataset considers nine ADL-related activities, which have been performed in different locations and involving the usage of both left and right arms. The dataset acquisition involved 10 volunteers performing 186 ADL instances, for a grand total of over 1860 examples. The dataset contains data from six 9-axis Inertial Measurement Units (IMUs), worn by each volunteer (two for each arm, one on the back and one on the right thigh). The dataset features an accurate data labelling done via manual annotation performed thanks to videos recorded by an RGB camera. The videos recorded during the experiments have been used only for labelling purposes, and they are not published.

SUBMITTER: Ruzzon M

PROVIDER: S-EPMC7452700 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

A multi-sensory dataset for the activities of daily living.

Ruzzon Marco M Carfì Alessandro A Ishikawa Takahiro T Mastrogiovanni Fulvio F Murakami Toshiyuki T

Data in brief 20200802

The article describes a multi-sensory dataset related to the Activities of Daily Living (ADL). These are the activities that contribute to an assessment of the overall status of elderly or people with special needs, possibly suffering from mild cognitive impairments. Typical basic ADLs include walking, such postural transitions as getting up or sitting down, as well as behaviours related to feeding, such as drinking or eating with knife and fork, or personal hygiene, e.g., teeth brushing. The co ...[more]

PMID: 32904359

Similar Datasets

Project description:Pathological proteins contributing to Alzheimer's disease (AD) are known to disrupt normal neuronal functions in the brain, leading to unbalanced neuronal excitatory-inhibitory tone, distorted neuronal synchrony, and network oscillations. However, it has been proposed that abnormalities in neuronal activity directly contribute to the pathogenesis of the disease, and in fact it has been demonstrated that induction of synchronized 40 Hz gamma oscillation of neuronal networks by sensory stimulation reverses AD-related pathological markers in transgenic mice carrying AD-related human pathological genes. Based on these findings, the current study evaluated whether non-invasive sensory stimulation inducing cortical 40 Hz gamma oscillation is clinically beneficial for AD patients. Patients with mild to moderate AD (n = 22) were randomized to active treatment group (n = 14; gamma sensory stimulation therapy) or to sham group (n = 8). Participants in the active treatment group received precisely timed, 40 Hz visual and auditory stimulations during eye-closed condition to induce cortical 40 Hz steady-state oscillations in 1-h daily sessions over a 6-month period. Participants in the sham group were exposed to similar sensory stimulation designed to not evoke cortical 40 Hz steady-state oscillations that are observed in the active treatment patients. During the trial, nighttime activities of the patients were monitored with continuous actigraphy recordings, and their functional abilities were measured by Alzheimer's Disease Cooperative Study - Activities of Daily Living (ADCS-ADL) scale. Results of this study demonstrated that 1-h daily therapy was well tolerated throughout the 6-month treatment period by all subjects. Patients receiving gamma sensory stimulation showed significantly reduced nighttime active periods, in contrast, to deterioration in sleep quality in sham group patients. Patients in the sham group also showed the expected, significant decline in ADCS-ADL scores, whereas patients in the gamma sensory stimulation group fully maintained their functional abilities over the 6-month period. These findings confirm the safe application of 40 Hz sensory stimulation in AD patients and demonstrate a high adherence to daily treatment. Furthermore, this is the first time that beneficial clinical effects of the therapy are reported, justifying expanded and longer trials to explore additional clinical benefits and disease-modifying properties of gamma sensory stimulation therapy. Clinical Trial Registration: clinicaltrials.gov, identifier: NCT03556280.

Dataset Information

A multi-sensory dataset for the activities of daily living.

Publications

A multi-sensory dataset for the activities of daily living.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets